Penserra Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33K Buy
+248
New +$30.5K ﹤0.01% 844
2021
Q4
– Sell
-27,989
Closed -$8.09M – 1516
2021
Q3
$8.09M Buy
+27,989
New +$7.18M 0.17% 175
2021
Q2
– Sell
-24,163
Closed -$4.7M – 1389
2021
Q1
$4.7M Sell
24,163
-12,835
-35% -$2.63M 0.09% 237
2020
Q4
$7.09M Buy
+36,998
New +$6.73M 0.17% 134
2020
Q2
– Sell
-435
Closed -$53K – 893
2020
Q1
$53K Buy
435
+159
+58% +$15.3K ﹤0.01% 664
2019
Q4
$28K Buy
+276
New +$23.2K ﹤0.01% 750
2019
Q3
– Sell
-110,565
Closed -$9.5M – 944
2019
Q2
$9.5M Buy
+110,565
New +$7.54M 0.74% 41

Other funds holding RGEN

Penserra Capital Management's RGEN Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 248 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #844 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in RGEN as recently as Q3 2021.

Penserra Capital Management first reported a position in RGEN in Q2 2019 and has held it in 7 quarters since. The position peaked at $9.5M in Q2 2019. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Penserra Capital Management held 248 shares of Repligen worth $33K as of Q2 2026.
  • Repligen was a new Penserra Capital Management position in Q2 2026.
  • Repligen made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #844 holding.
  • Penserra Capital Management first reported a position in Repligen in Q2 2019 and has held it in 7 quarters since.
  • Penserra Capital Management's Repligen position peaked at $9.5M in Q2 2019.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.